Correlation Between Edgewise Therapeutics and Immunoprecise Antibodies
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Immunoprecise Antibodies, you can compare the effects of market volatilities on Edgewise Therapeutics and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Immunoprecise Antibodies.
Diversification Opportunities for Edgewise Therapeutics and Immunoprecise Antibodies
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Immunoprecise is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Immunoprecise Antibodies go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Immunoprecise Antibodies
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 2.04 times more return on investment than Immunoprecise Antibodies. However, Edgewise Therapeutics is 2.04 times more volatile than Immunoprecise Antibodies. It trades about 0.29 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about 0.0 per unit of risk. If you would invest 1,808 in Edgewise Therapeutics on July 19, 2024 and sell it today you would earn a total of 1,695 from holding Edgewise Therapeutics or generate 93.75% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Immunoprecise Antibodies
Performance |
Timeline |
Edgewise Therapeutics |
Immunoprecise Antibodies |
Edgewise Therapeutics and Immunoprecise Antibodies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Immunoprecise Antibodies
The main advantage of trading using opposite Edgewise Therapeutics and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.Edgewise Therapeutics vs. Anebulo Pharmaceuticals | Edgewise Therapeutics vs. Champions Oncology | Edgewise Therapeutics vs. Celcuity LLC | Edgewise Therapeutics vs. Assembly Biosciences |
Immunoprecise Antibodies vs. Exscientia Ltd ADR | Immunoprecise Antibodies vs. Recursion Pharmaceuticals | Immunoprecise Antibodies vs. Atea Pharmaceuticals | Immunoprecise Antibodies vs. Unity Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data |